Four drug companies accused of illegal market sharing
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
List view / Grid view
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
A randomised clinical trial shows that the drug sorafenib tosylate extended progression-free survival compared with a placebo...